Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioncytoskeletal protein binding

SPTBN5 MISP AGBL5 KIF1C

7.64e-031099154GO:0008092
GeneOntologyCellularComponentvesicle tethering complex

TNFAIP2 COG3

1.19e-0372152GO:0099023
GeneOntologyCellularComponentcortical actin cytoskeleton

SPTBN5 MISP

1.98e-0393152GO:0030864
GeneOntologyCellularComponentcell cortex

SPTBN5 MISP TNFAIP2

2.15e-03371153GO:0005938
GeneOntologyCellularComponentcortical cytoskeleton

SPTBN5 MISP

3.76e-03129152GO:0030863
GeneOntologyCellularComponentmicrotubule associated complex

SPTBN5 KIF1C

5.80e-03161152GO:0005875
GeneOntologyCellularComponentmitotic spindle

MISP AGBL5

8.90e-03201152GO:0072686
Cytoband13q14.13

ZC3H13 COG3

2.87e-052316213q14.13
CytobandEnsembl 112 genes in cytogenetic band chr13q14

ZC3H13 COG3

3.21e-03244162chr13q14
DrugBaclofen (R,S) [1134-47-0]; Up 200; 18.8uM; PC3; HG-U133A

GLE1 ZC3H13 TNFAIP2 AGBL5

4.98e-061961441952_UP
Drugresveratrol; Down 200; 50uM; MCF7; HG-U133A

LAMA5 YLPM1 KIF1C

1.95e-04190143622_DN
Drug2-propylpentanoic acid; Up 200; 1000uM; MCF7; HG-U133A

ZC3H13 YLPM1 AGBL5

2.01e-0419214323_UP
DrugThioguanosine [85-31-4]; Up 200; 12.6uM; PC3; HT_HG-U133A

GLE1 YLPM1 KIF1C

2.04e-041931436643_UP
DrugNorethindrone [68-22-4]; Up 200; 13.4uM; PC3; HT_HG-U133A

GLE1 ZC3H13 TNFAIP2

2.07e-041941435055_UP
DrugEthynylestradiol 3-methyl ether [72-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A

SPTBN5 ZC3H13 TNFAIP2

2.10e-041951434792_UP
DrugChlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; HL60; HG-U133A

GLE1 TNFAIP2 YLPM1

2.10e-041951431371_DN
DrugMeptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; HL60; HT_HG-U133A

GLE1 YLPM1 KIF1C

2.10e-041951432906_UP
DrugMesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A

TNFAIP2 YLPM1 KIF1C

2.13e-041961432874_DN
Drugsulfasalazine; Down 200; 100uM; MCF7; HG-U133A

SPTBN5 ZC3H13 KIF1C

2.13e-04196143204_DN
DrugAmphotericin B [1397-89-3]; Up 200; 4.4uM; HL60; HT_HG-U133A

ZC3H13 TNFAIP2 KIF1C

2.13e-041961432441_UP
DrugRibostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; PC3; HT_HG-U133A

MISP YLPM1 KIF1C

2.13e-041961437123_DN
DrugPhenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A

GLE1 AGBL5 KIF1C

2.16e-041971433884_DN
Drug2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A

GLE1 TNFAIP2 KIF1C

2.16e-041971435211_DN
Drug1-phenylbiguanide hydrochloride; Up 200; 10uM; MCF7; HG-U133A

ZC3H13 YLPM1 AGBL5

2.16e-0419714322_UP
Drugphenformin hydrochloride; Up 200; 10uM; MCF7; HG-U133A

ZC3H13 YLPM1 AGBL5

2.16e-0419714321_UP
DrugHecogenin [467-55-0]; Down 200; 9.2uM; HL60; HT_HG-U133A

TNFAIP2 YLPM1 KIF1C

2.16e-041971432716_DN
DrugDoxazosin mesylate [77883-43-3]; Up 200; 7.4uM; HL60; HT_HG-U133A

LAMA5 MISP TNFAIP2

2.16e-041971433024_UP
DrugGlycopyrrolate [596-51-0]; Up 200; 10uM; HL60; HT_HG-U133A

MISP ZC3H13 TNFAIP2

2.16e-041971432565_UP
DrugTolmetin sodium salt dihydrate [64490-92-2]; Down 200; 12.6uM; HL60; HT_HG-U133A

SPTBN5 TNFAIP2 KIF1C

2.16e-041971433009_DN
Drugthioridazine hydrochloride; Up 200; 1uM; MCF7; HG-U133A

SPTBN5 ZC3H13 AGBL5

2.16e-04197143422_UP
DrugBendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A

TNFAIP2 YLPM1 KIF1C

2.16e-041971433415_DN
DrugTrimipramine maleate salt [521-78-8]; Up 200; 9.8uM; MCF7; HT_HG-U133A

SPTBN5 ZC3H13 KIF1C

2.20e-041981433342_UP
DrugTriamcinolone [124-94-7]; Down 200; 10.2uM; PC3; HT_HG-U133A

GLE1 TNFAIP2 KIF1C

2.20e-041981435835_DN
Drughaloperidol; Down 200; 10uM; MCF7; HT_HG-U133A

LAMA5 GLE1 YLPM1

2.20e-041981437003_DN
DrugDihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; PC3; HT_HG-U133A

GLE1 YLPM1 KIF1C

2.20e-041981432074_DN
DrugProparacaine hydrochloride [5875-06-9]; Down 200; 12uM; PC3; HT_HG-U133A

GLE1 TNFAIP2 YLPM1

2.20e-041981436332_DN
DrugTetramisole hydrochloride [16595-80-5]; Up 200; 16.6uM; HL60; HT_HG-U133A

GLE1 TNFAIP2 KIF1C

2.20e-041981432489_UP
DrugIopamidol [60166-93-0]; Down 200; 5.2uM; PC3; HT_HG-U133A

LAMA5 GLE1 KIF1C

2.23e-041991435832_DN
DrugRiluzole hydrochloride; Down 200; 14.8uM; PC3; HT_HG-U133A

TNFAIP2 YLPM1 KIF1C

2.23e-041991437365_DN
DrugMethylhydantoin-5-(D) [55147-68-7]; Up 200; 35uM; MCF7; HT_HG-U133A

SPTBN5 ZC3H13 KIF1C

2.23e-041991433333_UP
DrugScopolamin-N-oxide hydrobromide [6106-81-6]; Up 200; 10uM; MCF7; HT_HG-U133A

SPTBN5 ZC3H13 TNFAIP2

2.23e-041991435436_UP
Drug2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A

ZC3H13 TNFAIP2 KIF1C

2.23e-041991435219_UP
DrugLaudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A

GLE1 MUTYH TNFAIP2

2.23e-041991432890_DN
Diseaseplatelet crit

LAMA5 WDR24 YLPM1

1.14e-02952153EFO_0007985

Protein segments in the cluster

PeptideGeneStartEntry
RPRWERIRDRPTFEM

AGBL5

116

Q8NDL9
RDWLLRREDVLEECM

GLE1

26

Q53GS7
RRWLERMRRTFEEPT

KCNG3

151

Q8TAE7
ADPRRLCDLERERWA

MISP

131

Q8IVT2
WERVSRLMEEDPAFR

KIF1C

921

O43896
ERLRELERMLELGWE

GOLGA6L3

421

A6NEY3
ERLRELERMLELGWE

GOLGA6L4

446

A6NEF3
LAEVERLLWEMRARD

LAMA5

2316

O15230
RDAREKLALWDRRPD

COG3

16

Q96JB2
EEWRQRLERRLRMLD

FAM240B

51

A0A1B0GVZ2
RDLPWRRRAEDEMDL

MUTYH

106

Q9UIF7
RLRRSMEELENWLEP

SPTBN5

2791

Q9NRC6
LMDRALELEARRWAE

TNFAIP2

331

Q03169
EDRDDMLGWIRAIRE

ARHGAP23

791

Q9P227
APMERERLDDWDRER

YLPM1

1211

P49750
KRDYVPDRMDWERER

YLPM1

1386

P49750
PDRMDWERERLSDRW

YLPM1

1391

P49750
WDIRRPDRCERMFTA

WDR24

191

Q96S15
DADKDWPRNRDRDRL

ZC3H13

1326

Q5T200